GHK-Cu vs Wolverine (BPC-157 + TB-500)
GHK-Cu and Wolverine (BPC-157 + TB-500) are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.
How they actually differ
Comparing the two: GHK-Cu is tripeptide-copper(ii) complex (gly-his-lys : cu²⁺), while Wolverine (BPC-157 + TB-500) is two-component repair blend — bpc-157 (5 mg) + tb-500 (5 mg) in one 10 mg vial — different molecular classes with different handling consequences; they call for different primary diluents (sterile or bacteriostatic water versus bacteriostatic water (0.9% benzyl alcohol)); their leading degradation routes differ (copper dissociation at acidic ph for GHK-Cu, methionine oxidation of the tb-500 component, accelerated by light and trapped air for Wolverine (BPC-157 + TB-500)), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.
GHK-Cu — origin
GHK was identified by Loren Pickart in 1973 as a factor in human plasma whose concentration declines markedly with age. The decisive later finding was that its activity depends on chelated copper(II) — the peptide and the metal function as a unit. GHK-Cu is therefore a coordination complex, not simply a peptide, and it is the only such compound in this catalogue.
Wolverine (BPC-157 + TB-500) — origin
Wolverine combines the two most-studied tissue-repair peptides in a single 10 mg vial: BPC-157 (5 mg) and TB-500 (5 mg). It inherits the handling profile of both — the forgiving, gastric-derived BPC-157 and the oxidation-sensitive Thymosin-Beta-4 fragment TB-500 — so the blend is handled to the stricter of the two.
GHK-Cu research themes
The best-populated area of the GHK-Cu literature, examined in dermal fibroblast models.
Studied for effects on the MMP/TIMP balance governing matrix turnover.
Copper itself is an angiogenic cofactor, and the complex is studied in that context.
Plasma GHK falls substantially between early and later adulthood, a finding central to research interest in the molecule.
Wolverine (BPC-157 + TB-500) research themes
BPC-157 is studied around angiogenesis and growth-factor signalling; TB-500 around actin-mediated cell migration — non-overlapping routes into tissue repair.
Studied together in connective-tissue and wound-healing research designs where both mechanisms are of interest.
Because their mechanisms do not overlap, the two are frequently examined in parallel rather than as substitutes for one another.
GHK-Cu handling
- Never reconstitute in acidic diluent — low pH dissociates the copper complex.
- Keep chelating agents such as EDTA out of any buffer used with this compound.
- Treat colour change as a discard signal: clear blue is correct, pale or green is not.
- Avoid contact with reducing agents, which will reduce Cu(II) to Cu(I) and collapse the complex.
Wolverine (BPC-157 + TB-500) handling
- Reach room temperature before opening; the cake is hygroscopic.
- Add diluent gently down the wall and swirl; do not shake or vortex.
- Keep out of light and portion early, since every opening exposes the oxidation-sensitive TB-500 component to fresh air.
Both third-party tested
GHK-Cu and Wolverine (BPC-157 + TB-500) are third-party tested for HPLC purity and content, with the Certificate of Analysis for your batch available on request. Enter a lot number to pull a published COA.
GHK-Cu reference
Related comparisons
GHK-Cu and Wolverine (BPC-157 + TB-500) are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.